Skip to content
healthcare.dev

pazopanib

NDC 82293-022, pazopanib hydrochloride, tablet, film coated, from Novugen Pharma (USA) LLC..

Product NDC
82293-022
Status
Listed
Labeler
Novugen Pharma (USA) LLC.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218231
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82293-022 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PAZOPANIB HYDROCHLORIDE200 mg/1

Pharmacologic classes

Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]

Package NDCNDC-11Package
82293-022-1082293002210120 TABLET, FILM COATED in 1 BOTTLE (82293-022-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/25305d33-caa0-4577-8b7b-06e430c34c39

Use it

Look up 82293-022 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82293-022 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82293-022. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.